Holen Sie sich die Stockscreener-App
1.22
1.61%
-0.02
Handel nachbörslich:
1.25
0.03
+2.46%
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.05 | - | - |
Operating Expenses
|
69.75%
7.433
|
24.57 | 9.955 | 9.467 | 12.29 |
| Benefits Costs and Expenses |
-
|
- | - | -42.07 | - |
| Costs And Expenses |
69.75%
7.433
|
24.57 | 9.955 | -75.25 | 12.29 |
| Operating Income/Loss |
69.75%
-7.433
|
-24.57 | -9.905 | -9.467 | -12.29 |
| Nonoperating Income/Loss |
750.44%
0.961
|
0.113 | 0.166 | 0.249 | 0.193 |
| Income/Loss From Continuing Operations Before Tax |
73.54%
-6.472
|
-24.46 | -9.739 | 42.07 | -12.09 |
| Income/Loss From Continuing Operations After Tax |
73.54%
-6.472
|
-24.46 | -9.739 | 74.95 | -12.09 |
|
Net Income/Loss
|
73.54%
-6.472
|
-24.46 | -9.739 | -9.218 | -12.09 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
14.11%
26.59
|
23.30 | 22.50 | 0.7675 | 20.19 |
| Diluted Average Shares |
14.11%
26.59
|
23.30 | 22.50 | 0.7675 | 20.19 |
| Basic Earnings Per Share |
77.14%
-0.24
|
-1.05 | -0.43 | -0.40 | -0.60 |
| Diluted Earnings Per Share |
77.14%
-0.24
|
-1.05 | -0.43 | -0.40 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):